Informaは企業と専門家を数百の方法でサポートしています。

私たちの国際的なライブイベント、世界をリードする研究出版物、革新的なデジタルサービスのポートフォリオは、専門家が成功するために必要な知識と人脈を提供しています。

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2027
Grand Nikko Tokyo DaibaTokyo

Philip Kovach
Avidity Biosciences における Senior Scientist, Development Sciences
スピーカー

プロフィール

Philip Kovach is a Senior Scientist in Pharmacokinetics/Pharmacodynamics at Avidity Biosciences. He holds a Master of Science in Drug Development and Product Management from the UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences and has over 12 years of experience advancing antibody oligonucleotide conjugate (AOC) therapies from discovery through clinical development. His work spans bench science, bioanalytical strategy/execution for GLP and clinical studies, and contributions to clinical pharmacology analyses. Philip has supported del-zota (AOC 1044) for Duchenne muscular dystrophy since inception and is a contributing author on related publications and regulatory filings.

アジェンダセッション

  • Advancing RNA Therapeutics: Preclinical Translation of Antibody Oligonucleotide Conjugates (AOC)

    2:15pm